E
H. S. Rao et al.
Letter
Synlett
(7) (a) Aly, R.; Katz, H. I.; Kempers, S. E.; Lookingbill, D. P.; Lowe, N.;
Menter, A.; Morman, M.; Savin, R. C.; Wortzman, M. Int. J. Der-
matol. 2003, 42,01 : 19. (b) Niewerth, M.; Kunze, D.; Seibold, M.;
Schaller, M.; Korting, H. C.; Hube, B. Antimicrob. Agents Chemo-
ther. 2003, 47, 1805.
(23) Detailed information on the optimization of the reaction condi-
tions is given in Table 1 of the Supplementary Information.
(24) Kröhnke, F.; Zecher, W. Angew. Chem. 1962, 74, 811.
(25) Smith, C. L.; Hirschhäuser, C.; Malcolm, G. K.; Nasrallah, D. J.;
Gallagher, T. Synlett. 2014, 25, 1904.
(8) Tang, X.; Liu, P.; Li, R.; Jing, Q.; Lv, J.; Liu, L.; Liu, Y. Basic Clin.
Pharmacol. Toxicol. 2015, 117, 186.
(9) (a) Litvinov, V. P.; Krivokolysko, S. G.; Dyachenko, V. D. Chem.
Heterocycl. Compd. (Engl. Transl.) 1999, 35, 509. (b) Mijin, D. Ž.;
Ušćumlić, G. S.; Valentić, N. V.; Marinković, A. D. Hem. Ind. 2011,
65, 517;.
(26) (a) Arendt, J.; Rajaratnam, S. M. Br. J. Psychiatry 2008, 193, 267.
(b) Zlotos, D. P. Arch. Pharm. (Weinheim) 2005, 338, 229.
(27) (a) Rice, L. E.; Boston, M. C.; Finklea, H. O.; Suder, B. J.; Frazier, J.
O.; Hudlicky, T. J. Org. Chem. 1984, 49, 1845. (b) Fürstner, A. Syn-
thesis 1989, 571.
(28) Pyridin-2-ones 13a–m; General Procedure
(10) (a) Jessen, H. J.; Gademann, K. Nat. Prod. Rep. 2010, 27, 1168.
(b) Wang, S.; Cao, L.; Shi, H.; Dong, Y.; Sun, J.; Yuefei, H. Chem.
Pharm. Bull. 2005, 53, 67.
(11) Rawson, J. M.; Winpenny, R. E. P. Coord. Chem. Rev. 1995, 139,
313.
(12) (a) Imase, H.; Noguchi, K.; Hirano, M.; Tanaka, K. Org. Lett. 2008,
10, 3563. (b) Zhang, H.; Chen, B.-C.; Wang, B.; Chao, S. T.; Zhao,
R.; Lim, N.; Balasubramanian, B. Synthesis 2008, 1523. (c) Smith,
A. B. III.; Atasoylu, O.; Beshore, D. C. Synlett 2009, 2643. (d) Patel,
B. H.; Mason, A. M.; Barrett, A. G. M. Org. Lett. 2011, 13, 5156.
(e) Mijin, D. Ž.; Marković, J. M.; Brković, D. V.; Marinković, A. D.
Hem. Ind. 2014, 68, 1.
(13) Keller, P. A.; Abdel-Hamid, M. K.; Abdel-Megeed, A. M. Pyri-
dines: From Lab to Production; Scriven, E. F. V., Ed.; Academic
Press: Oxford, ; Chap. 2; 15.
(14) Kröhnke, F.; Zecher, W.; Curtze, J.; Drechsler, D.; Pfleghar, K.;
Schnalke, K. E.; Weis, W. Angew. Chem. Int. Ed. Engl. 1962, 1, 626.
(15) (a) Guareschi, I. Mem. Reale Accad. Sci. Torino II 1896, 46,
7,11,25. (b) Guareschi, I. Atti Accad. Sci. Torino 1900, 36, 443.
(c) Baron, H.; Remfry, F. G. P.; Thorpe, J. F. J. Chem. Soc. Trans
1904, 85, 1726;.
(16) Hantzsch, A. Justus Liebigs Ann. Chem. 1882, 215, 1.
(17) Chichibabin, A. E. Russ. J. Phys. Chem. 1905, 37, 1229.
(18) Petrenko-Kritschenko, P. J. Prakt. Chem. 1912, 85, 1.
(19) (a) Blaise, E. E. C. R. Hebd. Seances Acad. Sci. 1901, 132, 478.
(b) Blaise, E. E. C. R. Hebd. Seances Acad. Sci. 1901, 132, 987.
(c) Blaise, E. E. Bull. Soc. Chim. Fr. 1906, 35, 589. (d) For reviews,
see: Rao, H. S. P.; Rafi, S.; Padmavathy, K. Tetrahedron 2008, 64,
8037. (e) Kim, J. H.; Ko, Y. O.; Bouffard, J.; Lee, S.-g. Chem. Soc.
Rev. 2015, 44, 2489.
A solution of TMSCl (3 mol%) in anhyd 1,4-dioxane (1 mL) was
added to a suspension of Zn dust (2 equiv) in anhyd 1,4-dioxane
(3 mL), and the resulting suspension was refluxed with vigorous
stirring for 25 min. The appropriate nitrile (2 mmol) in dry 1,4-
dioxane (1 mL) and ethyl (E)-4-bromobut-2-enoate (12; 2
equiv) in dry 1,4-dioxane (1 mL) were simultaneously added
dropwise to the refluxing suspension during 10 min by using
two syringes. The resulting light-green mixture was refluxed
until all the starting material was consumed and the color
changed to brown (TLC; 3–6 h). The mixture was cooled to r.t.
then centrifuged (700 rpm). The upper solution was decanted
and the remaining solid was washed with 1,4-dioxane (4 × 1
mL). The 1,4-dioxane solutions were combined and concen-
trated to about 1 mL under reduced pressure in a rotatory evap-
orator. The residue was treated with 50% aq K2CO3 until the pH
reached 13 (~5 mL). The resulting mixture was stirred for 30
min at r.t. (30 °C) then diluted with CH2Cl2 (10 mL) and H2O (10
mL). The organic layer was separated, washed sequentially with
H2O (2 × 10 mL) and brine (10 mL), dried (Na2SO4), and evapo-
rated under reduced pressure to give a crude product that was
purified by column chromatography [silica gel (100–200 mesh);
15–60% EtOAc–hexane].
6-Phenylpyridin-2(1H)-one (13a)
By following the general procedure, the reaction of PhCN (5a;
201 mg, 1.94 mmol) with crotonate 12 (374 mg, 1.94 mmol) in
the presence of Zn (252 mg, 3.88 mmol) and TMSCl (7 mg, 3 mol
%) in 1,4-dioxane (6 mL) for 4 h, followed by hydrolysis with 50%
aq K2CO3 (5 mL) gave a light-yellow solid; yield: 205 mg (62%);
mp 194–195 °C; Rf = 0.5 (hexanes–EtOAc, 2:1).
IR (KBr): 2904, 1643, 1612, 1550, 1493, 990, 921, 795, 761 cm–1
.
(20) Rao, H. S. P.; Muthanna, N. Eur. J. Org. Chem. 2015, 1525.
(21) Rao, H. S. P.; Muthanna, N. Synlett. 2016, 27, 2014.
(22) Rao, H. S. P.; Rafi, S.; Padmavathy, K. Lett. Org. Chem. 2008, 5,
527.
1H NMR (400 MHz, CDCl3): δ = 12.49 (br s, 1 H), 7.72 (d, J = 6.9
Hz, 2 H), 7.59–7.40 (m, 4 H), 6.55–6.47 (m, 2 H). 13C NMR (100
MHz, CDCl3): δ = 165.4, 147.1, 141.5, 133.6, 130.1, 129.2, 126.8,
118.7, 105.0. HRMS (ESI): m/z [M + H] calcd for C11H9NO:
172.0762; found: 172.0750.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2018, 29, A–E